-The Business Standard Time to question the assumptions behind the food Bill In the midst of all the politicking as to how and when the draft food security Bill will become law, one thing at least is clear: the United Progressive Alliance (UPA) intends to push forward with the much-criticised legislation. UPA-II has little to show for four years in power, and perhaps it imagines that the Bill will somehow alter the...

-The United Nations Given the right conditions and targeted support, small farmers can unleash a new and sustainable agricultural revolution, the United Nations environment agency a partner agricultural development organization reported today on the eve of World Environment Day. According to the report, Smallholders, Food Security and the Environment, an estimated 2.5 billion people who manage 500 million smallholder farm households provide over 80 per cent of the food consumed in much...

-Down to Earth Report by children's non-profit links childhood malnourishment to educational performance, adult income and GDP Malnutrition decrease the gross domestic product (GDP) in low- and middle-income countries, says a report by international non-profit Save the Children. Malnutrition affects educational development, physical productivity and health, and also perpetuates inequalities, such as those created by caste in India, says the report. The report, Food for thought: Tackling child malnutrition to unlock potential...

Argumentative Indians are at it again! After sparring over the poverty line and the actual number of poor, India's renowned economists have fired up a fresh debate over the extent of malnutrition. In the earlier debate, the Planning Commission ‘reduced' poverty on paper disregarding NSSO and official committees, including the NCEUS, which determined that 77% Indians survived on less than Rs 20 a day. Columbia university economist Arvind Panagariya has...

-The Hindu   Ranbaxy's fraudulent practices may have jeopardised millions of lives in India, Africa and the U.S. Exactly two weeks ago, the pharmaceuticals industry was rocked by revelations that one of the world's largest generic drug manufacturers, Ranbaxy Laboratories, pleaded guilty to seven federal criminal charges stemming from its fraudulent production practices dating back to 2008, and agreed to pay U.S. regulators $500 million in fines. Much has since been said about Ranbaxy's...